[1]Chen W，Zheng R，Zeng H，et al．Annual report on status of cancer in China，2011．Chin J Cancer Res，2015，27（1）：2-12．

[2]Barber TW，Duong CP，Leong T，et al． ¹⁸F-FDG PET/CT Has a High Impact on Patient Management and Provides Powerful Prognostic Stratification in the Primary Staging of Esophageal Cancer：A Prospective Study with Mature Survival Data．J Nucl Med，2012，53：864-887．

[3]郭洪波，于金明，张百江，等． ¹⁸FDG PET/CT在术前检测食管癌淋巴结转移及分期中的应用．中华胸心血管外科杂志，2006，22（1）：28-31．

[4] ¹⁸F-FDG PET和PET/CT肿瘤学实践指南2012，美国．

[5]Fletcher JW，Djulbegovic B，Soares HP，et al．Recommendations on the use of ¹⁸F-FDG PET in oncology．J Nucl Med，2008，49：480-508．

[6]NCCN Clinical Practice Guidelines in Oncology（NCCN Guidelines ^Ⓡ）．Esophageal and Esophagogastric Junction Cancers V．1．2014．

[7]Krause BJ，Herrmann K，Wieder H，et al． ¹⁸F-FDG PET and ¹⁸F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer．J Nucl Med，2009，50：89S-96S．

[8]Wang YC，Hsieh TC，Yu CY，et al．The clinical application of 4D ¹⁸F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer．Journal of Radiation Research，2012，53：594-600．

[9]Muijs CT，Beukema JC，Pruim J，et al．A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer．Radiother Oncol，2010，97（2）：165-171．

[10]Pan L，Gu P，Huang G，et al．Prognostic significance of SUV on PET/CT in patients with esophageal cancer：a systematic review and meta-analysis．Eur J Gastroenterol Hepatol，2009，21（9）：1008-1015．

[11]中国抗癌协会食管癌专业委员会．食管癌规范诊疗指南（2010版）．北京：中国协和医科大学出版社，2011．